Market Price

Price is unknown


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18 Apr '19 Apr '20 Apr '21 Apr '22
Equity (BVPS) 12.46
13.41
14.03
12.77
31.99
33.20
30.60
33.23
35.52
31.12
growth rate 7.6% 4.6% -9.0% 150.5% 3.8% -7.8% 8.6% 6.9% -12.4%
Earnings BIT 4,795.00
4,972.00
5,719.00
6,110.00
6,545.00
6,709.00
5,162.00
5,515.00
6,602.00
growth rate 3.7% 15.0% 6.8% 7.1% 2.5% -23.1% 6.8% 19.7%
Avg.PE 26.22
26.97
35.13
35.13
35.13
35.13
29.95
growth rate 2.9% 30.3% 0.0% 0.0% 0.0% -14.8%
ROA 11.39
10.21
8.42
3.70
3.43
4.04
3.25
5.11
5.31
3.92
growth rate -10.4% -17.5% -56.1% -7.3% 17.8% -19.6% 57.2% 3.9% -26.2%
ROE 21.87
19.38
16.08
7.36
6.72
7.87
6.15
9.19
9.50
7.06
growth rate -11.4% -17.0% -54.2% -8.7% 17.1% -21.9% 49.4% 3.4% -25.7%
ROIC 13.97
12.62
10.44
4.79
5.00
5.59
4.67
7.80
7.40
5.83
growth rate -9.7% -17.3% -54.1% 4.4% 11.8% -16.5% 67.0% -5.1% -21.2%
Cur. Ratio 1.62
4.57
3.82
3.36
3.29
1.75
2.28
2.59
2.13
2.65
growth rate 182.1% -16.4% -12.0% -2.1% -46.8% 30.3% 13.6% -17.8% 24.4%
Quick Ratio 1.09
3.94
3.38
2.83
2.64
1.36
1.71
1.90
1.50
1.91
growth rate 261.5% -14.2% -16.3% -6.7% -48.5% 25.7% 11.1% -21.1% 27.3%
Leverage 1.93
1.87
1.95
2.00
1.92
1.98
1.80
1.79
1.79
1.81
growth rate -3.1% 4.3% 2.6% -4.0% 3.1% -9.1% -0.6% 0.0% 1.1%
Balance Sheet Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18 Apr '19 Apr '20 Apr '21 Apr '22
Acct.Receivable 4,266.00
4,547.00
5,112.00
5,562.00
7,182.00
7,913.00
7,951.00
4,645.00
5,462.00
5,551.00
growth rate 6.6% 12.4% 8.8% 29.1% 10.2% 0.5% -41.6% 17.6% 1.6%
Acct.Payable 681.00
742.00
1,610.00
1,709.00
1,555.00
1,628.00
1,953.00
1,996.00
2,106.00
2,276.00
growth rate 9.0% 117.0% 6.2% -9.0% 4.7% 20.0% 2.2% 5.5% 8.1%
Cur.Assets 17,852.00
21,210.00
30,844.00
23,600.00
26,956.00
24,974.00
24,084.00
22,031.00
22,548.00
23,059.00
growth rate 18.8% 45.4% -23.5% 14.2% -7.4% -3.6% -8.5% 2.4% 2.3%
Total Assets 34,900.00
37,943.00
106,685.00
99,644.00
99,948.00
91,403.00
89,694.00
90,689.00
93,083.00
90,981.00
growth rate 8.7% 181.2% -6.6% 0.3% -8.6% -1.9% 1.1% 2.6% -2.3%
Cash 919.00
1,403.00
4,843.00
2,876.00
4,967.00
3,669.00
4,393.00
4,140.00
3,593.00
3,714.00
growth rate 52.7% 245.2% -40.6% 72.7% -26.1% 19.7% -5.8% -13.2% 3.4%
Inventory 1,712.00
1,725.00
3,463.00
3,473.00
3,338.00
3,579.00
3,753.00
4,229.00
4,313.00
4,616.00
growth rate 0.8% 100.8% 0.3% -3.9% 7.2% 4.9% 12.7% 2.0% 7.0%
Cur.Liabilities 3,950.00
5,559.00
9,173.00
7,165.00
13,043.00
8,363.00
6,987.00
10,366.00
8,509.00
12,394.00
growth rate 40.7% 65.0% -21.9% 82.0% -35.9% -16.5% 48.4% -17.9% 45.7%
Liabilities 16,229.00
18,500.00
53,455.00
47,581.00
49,618.00
40,674.00
39,482.00
39,817.00
41,481.00
38,259.00
growth rate 14.0% 189.0% -11.0% 4.3% -18.0% -2.9% 0.9% 4.2% -7.8%
LT Debt 9,607.00
10,187.00
33,694.00
30,135.00
25,909.00
23,698.00
24,476.00
21,976.00
26,316.00
20,316.00
growth rate 6.0% 230.8% -10.6% -14.0% -8.5% 3.3% -10.2% 19.8% -22.8%
Equity 19,443.00
53,230.00
52,063.00
50,208.00
50,627.00
50,091.00
50,737.00
51,428.00
52,551.00
growth rate 173.8% -2.2% -3.6% 0.8% -1.1% 1.3% 1.4% 2.2%
Common Shares 1,060.00
1,028.00
1,014.00
1,109.00
1,426.00
1,391.00
1,368.00
1,358.00
1,351.00
1,354.00
growth rate -3.0% -1.4% 9.4% 28.6% -2.5% -1.7% -0.7% -0.5% 0.2%
Cash Flow Statement Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18 Apr '19 Apr '20 Apr '21 Apr '22
Capital Expenditures 457.00
396.00
571.00
1,046.00
1,254.00
1,068.00
1,134.00
1,213.00
1,355.00
1,368.00
growth rate -13.4% 44.2% 83.2% 19.9% -14.8% 6.2% 7.0% 11.7% 1.0%
Cash Dividends 1,116.00
1,337.00
2,139.00
2,376.00
2,494.00
2,693.00
2,894.00
3,120.00
3,383.00
growth rate 19.8% 60.0% 11.1% 5.0% 8.0% 7.5% 7.8% 8.4%
Cash From OA 4,942.00
4,959.00
4,902.00
5,218.00
6,880.00
4,684.00
7,007.00
7,234.00
6,240.00
7,346.00
growth rate 0.3% -1.2% 6.5% 31.9% -31.9% 49.6% 3.2% -13.7% 17.7%
FCF per Share 2.83
3.16
3.16
3.50
2.99
3.39
2.59
3.20
4.53
2.83
growth rate 11.7% 0.0% 10.8% -14.6% 13.4% -23.6% 23.6% 41.6% -37.5%
Sale Purchase of Stock 1,307.00
649.00
491.00
428.00
403.00
growth rate -50.3% -24.4% -12.8% -5.8%
FCF 3,971.00
4,426.00
4,563.00
4,331.00
4,172.00
5,626.00
3,616.00
5,873.00
6,021.00
4,885.00
5,978.00
growth rate 11.5% 3.1% -5.1% -3.7% 34.9% -35.7% 62.4% 2.5% -18.9% 22.4%
Income Statement Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18 Apr '19 Apr '20 Apr '21 Apr '22
Sales 16,569.00
16,893.00
20,261.00
28,833.00
29,710.00
29,953.00
30,557.00
28,913.00
30,117.00
31,686.00
growth rate 2.0% 19.9% 42.3% 3.0% 0.8% 2.0% -5.4% 4.2% 5.2%
Op.Income 3,467.00
4,795.00
4,972.00
5,719.00
6,110.00
6,545.00
6,709.00
5,162.00
5,515.00
6,602.00
growth rate 38.3% 3.7% 15.0% 6.8% 7.1% 2.5% -23.1% 6.8% 19.7%
IBT 3,705.00
3,486.00
4,336.00
4,602.00
5,675.00
5,197.00
4,055.00
3,895.00
5,517.00
growth rate -5.9% 24.4% 6.1% 23.3% -8.4% -22.0% -4.0% 41.6%
Net Income 3,467.00
3,065.00
2,675.00
3,538.00
4,028.00
3,104.00
4,631.00
4,789.00
3,606.00
5,039.00
growth rate -11.6% -12.7% 32.3% 13.9% -22.9% 49.2% 3.4% -24.7% 39.7%
EPS 3.41
3.37
3.02
2.41
2.48
2.89
2.27
3.41
3.54
2.66
growth rate -1.2% -10.4% -20.2% 2.9% 16.5% -21.5% 50.2% 3.8% -24.9%
Gross Profit 12,474.00
12,682.00
14,590.00
19,926.00
20,464.00
20,914.00
21,493.00
19,644.00
19,762.00
21,657.00
growth rate 1.7% 15.0% 36.6% 2.7% 2.2% 2.8% -8.6% 0.6% 9.6%
R&D 1,477.00
1,640.00
2,224.00
2,193.00
2,256.00
2,330.00
2,331.00
2,493.00
2,746.00
growth rate 11.0% 35.6% -1.4% 2.9% 3.3% 0.0% 7.0% 10.2%

Quarterly Statements

Item Name Jul '21 Oct '21 Jan '22 Apr '22 Jul '22
Earnings BIT 1,665.00
1,637.00
1,668.00
1,891.00
1,168.00
growth rate -1.7% 1.9% 13.4% -38.2%
Balance Sheet Jul '21 Oct '21 Jan '22 Apr '22 Jul '22
Acct.Receivable 5,431.00
5,493.00
5,446.00
5,551.00
5,308.00
growth rate 1.1% -0.9% 1.9% -4.4%
Acct.Payable 1,864.00
1,917.00
1,985.00
2,276.00
2,180.00
growth rate 2.8% 3.6% 14.7% -4.2%
Cur.Assets 22,434.00
22,731.00
23,303.00
23,059.00
22,135.00
growth rate 1.3% 2.5% -1.1% -4.0%
Total Assets 91,802.00
91,756.00
91,804.00
90,981.00
89,914.00
growth rate -0.1% 0.1% -0.9% -1.2%
Cash 3,004.00
2,900.00
3,479.00
3,714.00
2,140.00
growth rate -3.5% 20.0% 6.8% -42.4%
Inventory 4,288.00
4,349.00
4,514.00
4,616.00
4,809.00
growth rate 1.4% 3.8% 2.3% 4.2%
Cur.Liabilities 7,764.00
7,803.00
8,927.00
12,394.00
14,049.00
growth rate 0.5% 14.4% 38.8% 13.4%
Liabilities 40,138.00
39,597.00
39,091.00
38,259.00
37,072.00
growth rate -1.4% -1.3% -2.1% -3.1%
LT Debt 25,898.00
25,548.00
24,232.00
20,316.00
17,423.00
growth rate -1.4% -5.2% -16.2% -14.2%
Equity 51,486.00
51,991.00
52,542.00
52,551.00
52,672.00
growth rate 1.0% 1.1% 0.0% 0.2%
Common Shares
growth rate
Cash Flow Statement Jul '21 Oct '21 Jan '22 Apr '22 Jul '22
Capital Expenditures 378.00
271.00
330.00
389.00
426.00
growth rate -28.3% 21.8% 17.9% 9.5%
Cash Dividends 846.00
847.00
847.00
843.00
903.00
growth rate 0.1% 0.0% -0.5% 7.1%
Cash From OA 1,292.00
1,769.00
2,228.00
2,057.00
1,083.00
growth rate 36.9% 26.0% -7.7% -47.4%
Sale Purchase of Stock
growth rate
FCF 914.00
1,498.00
1,898.00
1,668.00
657.00
growth rate 63.9% 26.7% -12.1% -60.6%
Income Statement Jul '21 Oct '21 Jan '22 Apr '22 Jul '22
Sales 7,987.00
7,847.00
7,763.00
8,089.00
7,371.00
growth rate -1.8% -1.1% 4.2% -8.9%
Op.Income 1,665.00
1,637.00
1,668.00
1,891.00
1,168.00
growth rate -1.7% 1.9% 13.4% -38.2%
IBT 833.00
1,493.00
1,590.00
1,601.00
1,043.00
growth rate 79.2% 6.5% 0.7% -34.9%
Net Income 763.00
1,311.00
1,480.00
1,485.00
929.00
growth rate 71.8% 12.9% 0.3% -37.4%
Gross Profit 5,422.00
5,381.00
5,330.00
5,524.00
4,874.00
growth rate -0.8% -1.0% 3.6% -11.8%
R&D 750.00
676.00
668.00
652.00
692.00
growth rate -9.9% -1.2% -2.4% 6.1%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (26.87)

YOY Growth Grade:

E (21.11)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 23.72 23.92 11.54
EPS / Growth 6.6% 3.06 13.6%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 2.6%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 2.6% 4.6% 4.6%
Future PE 5.16 14.81 14.81
Future EPS 3.95 4.79 4.79
Value Price
MOS %
5.04
17.53
17.53
MOS Price 2.52 8.76 8.76
IRT

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.